Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

On Assignment Inc

Article Abstract:

On Assigning Inc.'s performance in 2002 was lackluster especially in the healthcare personnel options segment due to the weak economic environment. Shares are untimely for selection during the next 6 - 12 months but is a good entry point for long-term investors.

Author: Ferrara, J. Susan
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Personnel Supply Services, Employment Services, On Assignment Inc. (Calabasas, California), ASGN

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


ISIS Pharmaceuticals

Article Abstract:

Isis Pharmaceutical Inc.'s experimental drug failed to prove its efficiency but has managed to strengthen its balance sheet so the issue has speculative appeal.

Author: Ferrara, J. Susan
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Product information, Pharmaceutical industry, Isis Pharmaceuticals Inc., ISIP

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Finance, Company investment, Investments, Statistics, Securities, Company sales and earnings, Company earnings/profit, Company securities, Company business forecast/projection, Company forecasts
Similar abstracts:
  • Abstracts: Omnicare, Inc.. NPS Pharma Inc
  • Abstracts: Arvinmeritor Inc. Genuine Parts Co. Borgwarner Inc
  • Abstracts: Millenium Pharmaceuticals Inc. Sepracor
  • Abstracts: Sunrise Assited Living Inc. Brush Engineered Materials
  • Abstracts: Abgenix Inc. Cerner Corp. Healthcare information services
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.